Trial
NCT01244503
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
Meridian Bioscience, Inc.
Condition
Metabolic Syndrome
Intervention
Sodium Octanoate Breath Test
Why stopped
Budgetary Issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-28